Search

The interaction between oxyresveratrol (a type of stilbene with high biological activity) and modified cyclodextrins (CDs) was studied. Using HPLC-RP, was seen to form a 1:1 complex with all the CDs tested. The best CD in this respect was MβCD (K F = 606.65 ± 30.18 M −1 ), the complexation showing a strong dependence on pH and temperature: The complexation constant (K F ) decreased as the pH and temperature increased. The thermodynamic parameters studied (ΔH°, ΔS° and ΔG°) showed negative entropy, enthalpy and Gibbs free energy change at 25 °C. In addition, fluorescence signal of oxyresveratrol increased when MβCD was added. The oxyresveratrol emission and excitation spectra were obtained for first time. A 1 H NMR was carried out to study the structure of the complex and, DSC studied demonstrated the complexation. A computational study by molecular docking was made to complement the structural study. [ABSTRACT FROM AUTHOR]

• The complexation constant between CD-NS and OXY was calculated. • C. elegans PDE4 was heterologously expressed and in vitro characterized. • The inhibition profile of OXY against PDE4 showed a competitive behavior. • An in silico study confirmed the in vitro PDE4 inhibition results. • The in vivo lifespan on C. elegans increased when when OXY is complexed in CD-NS. In this work, the increase of the Caenorhabditis elegans (C. elegans) lifespan extension using hyper-branched cyclodextrin-based nanosponges (CD-NS) complexing oxyresveratrol (OXY), and the possible inhibition of C. elegans phosphodiesterase type 4 (PDE4) were evaluated. The titration displacement of fluorescein was used to calculate the apparent complexation constant (K F) between CD-NS and OXY. Moreover, PDE4 was expressed in E. coli , purified and refolded in presence of cyclodextrins (CDs) to study its possible inhibition as pharmacological target of OXY. The apparent activity was characterized and the inhibitory effect of OXY on PDE4 displayed a competitive in vitro inhibition corroborated in silico. A maximum increase of the in vivo life expectancy of about 9.6% of using OXY/CD-NS complexes in comparison with the control was obtained, in contrast to the 6.5% obtained with free OXY. No effect on lifespan or toxicity with CD-NS alone was found. These results as a whole represent new opportunities to use OXY and CD-NS in lifespan products. [ABSTRACT FROM AUTHOR]

• A way to calculate the apparent constant between a ligand and CDNS was determined for the first time. • The apparent constants using different CDs and linker ratios were calculated. • The OXY/β-CD-CDI 1:4 complex was studied in vitro with DSC, TGA and FTIR techniques. • The apparent constant of the resveratrol/β-CD-CDI 1:4 complex was also studied. • An in cellulo anticancer activity study was carried out with the PC-3, HT-29 and HCT116 cell. The complexation of the bioactive compound oxyresveratrol (OXY) with a polymer called cyclodextrin-based nanosponge (CD-NS) and its application was studied.A new methodology is used to calculate, an apparent inclusion complex constant (K Fapp) between a ligand and CD-NSs. Moreover, the K Fapp of resveratrol was also evaluated and compared. The complex of OXY with the nanosponge β-CDI 1:4, was studied in vitro using DSC, TGA and FTIR techniques and its drug loading and release behavior were studied. An in vitro digestion showed higher protection of OXY complexed than free OXY. The bioactivity enhancing capacity of OXY was also studied against prostate (PC-3) and colon (HT-29 and HCT-116) cancer cell lines, where it showed stronger cell viability inhibition than the free drug. The findings as a whole represent a new opportunity for studying the complexation of drugs in CD-NSs and the use of oxyresveratrol as an ingredient in nutraceutical products. [ABSTRACT FROM AUTHOR]

Despite being saturated, a huge quantity of "novel" functional food products reaches the food market every day and companies are looking for new products to catch consumers' attention. In the present study, the inclusion complexes of oxyresveratrol with α-, β- and γ-CD are characterized using DSC, TGA, SEM and molecular docking and their complexing capacities arecompared. As β-CD showed the best results, i) 0.2 mM oxyresveratrol alone, ii) 0.2 mM oxyresveratrol complexed with 8 mM β-CD and iii) 4 mM oxyresveratrol solubilized with 8 mM β-CD were used to fortify, juice and milk food models, and kept in typical storage conditions (darkness and/or refrigerated) conditions for one month. The results showed that CD supplementation leads to a higher oxyresveratrol concentration and antioxidant capacity than when not used. Oxyresveratrol/β-CD food models were stable for five weeks. The most typical variables measured were compared. In vitro digestion pointed to similar bioaccessibility. The bacteriostatic effect was also studied and the greater effectiveness of oversaturated solutions was demostrated. These results should be useful for the food industry for designing hydrophilic products containing oxyresveratrol. Image 1 • An exhaustive comparative study of the oxyresveratrol complexes with α-, β- and γ-CD was carried out. • 60 different samples (type of food model, storage conditions and solution) were evaluated. • The pH values and °Brix were stable for 5 weeks. • Concentration decrease around 5-0%, with the exception of milk food model. • Dark storage showed to be the most stable. [ABSTRACT FROM AUTHOR]

Resveratrol and oxyresveratrol are natural polyphenolic stilbenes with several important pharmacological activities. However, low solubility and aqueous instability are the major limitations in their drug delivery applications. In the present work, we demonstrated the encapsulation of resveratrol and oxyresveratrol with nanosponge to improve solubility and stability. Several characterization techniques were used to confirm the encapsulation of both drug molecules within the nanosponges. The high encapsulation efficiency of resveratrol (77.73%) and oxyresveratrol (80.33%) was achieved within the nanosponges. Transmission electron microscopy suggested uniform spherical size particles of resveratrol and oxyresveratrol loaded nanosponges. Compared to free drugs, better protection against UV degradation was observed for resveratrol-loaded nanosponge (2-fold) and oxyresveratrol-loaded nanosponge (3-fold). Moreover, a higher solubilization of resveratrol- and oxyresveratrol-loaded nanosponges lead to a better antioxidant activity compared to drug molecules alone. Cytotoxicity studies against DU-145 prostate cancer cell lines further suggested improved activity of both resveratrol and oxyresveratrol-loaded nanosponges without any significant toxicity of blank nanosponges. [ABSTRACT FROM AUTHOR]